CD33 and amyloidosis: Still, the several studies showing different effects of CD33 in AD, such as an elevated expression in AD brain associated with amyloid pathology, disease progression, and microglial activation may reflect the important role of CD33 biological pathway in AD, most likely dependent on TREM227.